Literature DB >> 28017663

Onartuzumab ineffective in non-small-cell lung cancer.

Vicki Brower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28017663     DOI： 10.1016/S1470-2045(16)30680-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis.

Authors:  Tobias Raphael Overbeck; Dana Alina Cron; Katja Schmitz; Achim Rittmeyer; Wolfgang Körber; Sara Hugo; Juliane Schnalke; Laura Lukat; Tabea Hugo; Marc Hinterthaner; Kirsten Reuter-Jessen; Tessa Rosenthal; Joachim Moecks; Annalen Bleckmann; Hans-Ulrich Schildhaus
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 2.  Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer.

Authors:  Oshin Miranda; Mariya Farooqui; Jill M Siegfried
Journal:  Cancers (Basel)       Date:  2018-08-21       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.